Journal of Neurological Surgery Part B Skull Base · 2017 · 51 citations · 21 references
MedicineGeneticsOncologyCancer GeneticsMolecular OncologyNeoplasiaCancer Molecular PathologyMalignant NeoplasmsMolecular Tumor ProfilingNext-generation Sequencing In OncologyOncogenic Signaling PathwaysSinonasal CancerCancer Mutation AnalysisDriver Mutation DiscoveryDriver Mutation IdentificationImmunohistochemical StainingMutations In Wnt Signaling PathwayOncogenic Driver MutationsSkull Base MalignanciesTumor Mutation Analysis
Objective Sinonasal teratocarcinosarcomas are rare, aggressive tumors of the skull base. Treatment options are limited and outcomes are poor. Little is known in regard to the genetic factors regulating these tumors. Characterization of actionable molecular alterations in these tumors could provide potentially successful therapeutic options. Methods We performed targeted exome sequencing on an index sinonasal teratocarcinosarcoma specimen to identify potential driver mutations. We performed immunohistochemical stains for β-catenin on paraffin-embedded tissue on the index tumor and a subsequent teratocarcinosarcoma. Online databases of cancer mutations (Catalogue of Somatic Mutations in Cancer and The Cancer Genome Atlas) were accessed. Results We identified an activating p.S45F mutation in β-catenin in our index sinonasal teratocarcinosarcoma. This mutation results in constitutive signaling in the Wnt/β-catenin pathway. We confirmed β-catenin overexpression and nuclear localization via immunohistochemistry in the index tumor and a second patient. The p.S45F activating mutation was found in a variety of solid tumors, and accounts for 3.3 to 10.4% of all known β-catenin mutations. Conclusion We identified a potential driver mutation in β-catenin in a sinonasal teratocarcinosarcoma, resulting in β-catenin overexpression. These findings suggest a role for the Wnt/β-catenin pathway in sinonasal teratocarcinosarcoma tumorigenesis and a role for anti-β-catenin targeted therapy.
21
The Cancer Genome Atlas Pan-Cancer analysis project
John N. Weinstein, Gordon B. Mills, Kenna Shaw et al. · Nature Genetics · 2013 · 9.5K citations · Full text
Activation of β-Catenin-Tcf Signaling in Colon Cancer by Mutations in β-Catenin or APC
Patrice J. Morin, Andrew B. Sparks, Vladimír Kořínek et al. · Science · 1997 · 3.9K citations
COSMIC: exploring the world's knowledge of somatic mutations in human cancer
Simon Forbes, David Beare, Prasad Gunasekaran et al. · Nucleic Acids Research · 2014 · 2.4K citations · Full text
Stabilization of β-Catenin by Genetic Defects in Melanoma Cell Lines
Bonnee Rubinfeld, Paul F. Robbins, Mona El‐Gamil et al. · Science · 1997 · 1.2K citations